Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Current role of short-term intensive insulin strategies in newly diagnosed type 2 diabetes.

Xu W, Weng J.

J Diabetes. 2013 Sep;5(3):268-74. doi: 10.1111/1753-0407.12054. Epub 2013 May 29. Review.

PMID:
23551748
2.

Short-term intensified insulin treatment in type 2 diabetes: long-term effects on β-cell function.

Retnakaran R, Zinman B.

Diabetes Obes Metab. 2012 Oct;14 Suppl 3:161-6. doi: 10.1111/j.1463-1326.2012.01658.x. Review.

PMID:
22928577
4.

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H.

Lancet. 2008 May 24;371(9626):1753-60. doi: 10.1016/S0140-6736(08)60762-X.

PMID:
18502299
5.

Insulin therapy in type 2 diabetes.

Mudaliar S, Edelman SV.

Endocrinol Metab Clin North Am. 2001 Dec;30(4):935-82. Review.

PMID:
11727406
6.
7.

Determinants of reversibility of β-cell dysfunction in response to short-term intensive insulin therapy in patients with early type 2 diabetes.

Kramer CK, Choi H, Zinman B, Retnakaran R.

Am J Physiol Endocrinol Metab. 2013 Dec 1;305(11):E1398-407. doi: 10.1152/ajpendo.00447.2013. Epub 2013 Oct 15.

8.

[The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].

Liu SP, Mo H, Liu BL, Tang WL, Deng XG, Su X, Yao L, Lin J, Feng Q, Peng J, Zhou ZG, Li YJ.

Zhonghua Nei Ke Za Zhi. 2010 May;49(5):405-9. Chinese.

PMID:
20646415
9.

Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission.

Hu Y, Li L, Xu Y, Yu T, Tong G, Huang H, Bi Y, Weng J, Zhu D.

Diabetes Care. 2011 Aug;34(8):1848-53. doi: 10.2337/dc10-2105. Epub 2011 Jun 16.

10.

Short-term intensive insulin therapy in newly diagnosed type 2 diabetes.

Ryan EA, Imes S, Wallace C.

Diabetes Care. 2004 May;27(5):1028-32.

PMID:
15111515
11.

Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment.

Chen A, Huang Z, Wan X, Deng W, Wu J, Li L, Cai Q, Xiao H, Li Y.

Diabetes Care. 2012 Mar;35(3):474-81. doi: 10.2337/dc11-1638. Epub 2012 Jan 6.

12.

The effect of early insulin therapy on pancreatic β-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients.

Chon S, Oh S, Kim SW, Kim JW, Kim YS, Woo JT.

Korean J Intern Med. 2010 Sep;25(3):273-81. doi: 10.3904/kjim.2010.25.3.273. Epub 2010 Aug 31.

13.

Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes.

Mu PW, Chen YM, Lu HY, Wen XQ, Zhang YH, Xie RY, Shu J, Wang MM, Zeng LY.

Diabetes Metab Res Rev. 2012 Mar;28(3):236-40. doi: 10.1002/dmrr.1292.

PMID:
21898754
14.

Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission.

Liu L, Ke W, Wan X, Zhang P, Cao X, Deng W, Li Y.

Diabetes Res Clin Pract. 2015 May;108(2):250-7. doi: 10.1016/j.diabres.2015.02.011. Epub 2015 Feb 21.

PMID:
25765670
15.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
16.
17.

Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients.

Liu J, Liu J, Fang D, Liu L, Huang Z, Wan X, Cao X, Li Y.

Endocr J. 2013;60(6):725-32. Epub 2013 Feb 20.

18.

Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.

Ilkova H, Glaser B, Tunçkale A, Bagriaçik N, Cerasi E.

Diabetes Care. 1997 Sep;20(9):1353-6.

PMID:
9283777
19.

The response to short-term intensive insulin therapy in type 2 diabetes.

Retnakaran R, Yakubovich N, Qi Y, Opsteen C, Zinman B.

Diabetes Obes Metab. 2010 Jan;12(1):65-71. doi: 10.1111/j.1463-1326.2009.01129.x. Epub 2009 Sep 9.

PMID:
19740080
20.

Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.

Li Y, Xu W, Liao Z, Yao B, Chen X, Huang Z, Hu G, Weng J.

Diabetes Care. 2004 Nov;27(11):2597-602.

PMID:
15504992

Supplemental Content

Support Center